Thymosin Alpha-1: The Most Clinically Proven Peptide in Integrative Medicine
July 16, 2026

Every peptide in this series has required some version of the same honest disclaimer: the human evidence is early, the trials are small, and the data is promising but not yet definitive. Dr. DiFrancesco has written that disclosure four times now, for CJC-1295, AOD-9604, TB-500, and BPC-157. Thymosin Alpha-1 is different. Categorically. This is a […]

Continue Reading
BPC-157 Peptide Therapy: Mechanisms, Evidence, and What Atlanta Patients Should Know
July 8, 2026

BPC-157, or Body Protection Compound-157, is a synthetic version of a sequence found naturally in human gastric juice, where it plays a role in protecting the mucosal lining of the gastrointestinal tract. This origin matters clinically. It is part of why BPC-157 has one of the most interesting safety profiles in the peptide therapy space, […]

Continue Reading
TB-500 Peptide Therapy: A Plastic Surgeon’s Guide to This Regenerative Healing Compound
June 29, 2026

Most discussions of TB-500 take place in athletic recovery circles, centered on torn tendons, strained muscles, and injuries that refuse to resolve. That context is legitimate. At DiFrancesco Plastic Surgery, however, TB-500 is viewed through a different lens entirely, one grounded in the biology of wound healing, tissue remodeling, and surgical recovery. Because plastic surgery […]

Continue Reading